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ABSTRACT 
Multidrug resistance (MDR) is believed to be responsible for poor response of patients 
towards chemotherapy particularly patients with acute myeloid leukemia (AML) and acute 
lymphoblastic leukemia (ALL). The best-characterized resistance mechanism is the one 
mediated by permeability-glycoprotein (P-gp) encoded by MDR1 gene, which is responsible 
for drug efflux. We studied P-gp and multidrug resistance-associated protein 1 (MRP1) 
expression and functional activities in 43 newly diagnosed acute leukemia cases (19 
paediatric ALL cases and 24 adult AML cases). The expression and functional activities were 
examined using flow cytometry and MultiDrugQuant assay kit (involving calcein AM uptake 
and efflux). P-gp and MRP1 expression and its functional activities were observed in 68.4% 
of paediatric ALL. In adult AML cases, all cases expressed MRP1 and its functional activities 
but only 58.3% were positive for P-gp and its functional activities. We were able to show a 
significant correlation between the expression of the multidrug resistant protein (P-gp and 
MRP1) and their functional activity in adult AML and paediatric ALL samples. 
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